Get the Stockscreener App
1.84
0.00%
0.00
After Hours:
1.77
-0.07
-3.80%
Repare Therapeutics Inc stock is traded at $1.84, with a volume of 179.93K.
It is up +0.00% in the last 24 hours and up +2.22% over the past month.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.
See More
Previous Close:
$1.84
Open:
$1.84
24h Volume:
179.93K
Relative Volume:
1.44
Market Cap:
$79.04M
Revenue:
$51.13M
Net Income/Loss:
$-93.80M
P/E Ratio:
-0.8251
EPS:
-2.23
Net Cash Flow:
$-129.10M
1W Performance:
-1.60%
1M Performance:
+2.22%
6M Performance:
+28.67%
1Y Performance:
-48.60%
1-Day Range:
$1.75
$1.86
1-Week Range:
$1.72
$1.885
52-Week Range:
$0.89
$4.0695
Repare Therapeutics Inc Stock (RPTX) Company Profile
Name
Repare Therapeutics Inc
Sector
Industry
Phone
(857) 412-7018
Address
7171 FREDERICK BANTING, SAINT-LAURENT, QC
Compare RPTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RPTX
Repare Therapeutics Inc
|
1.84 | 79.04M | 51.13M | -93.80M | -129.10M | -2.23 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Repare Therapeutics Inc Stock (RPTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-09-23 | Upgrade | Stifel | Hold → Buy |
| Feb-03-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-06-23 | Initiated | CapitalOne | Overweight |
| Apr-12-22 | Downgrade | Stifel | Buy → Hold |
| Mar-17-22 | Resumed | Goldman | Buy |
| Sep-23-21 | Initiated | Stifel | Buy |
| Sep-13-21 | Initiated | H.C. Wainwright | Buy |
| Jun-28-21 | Initiated | Guggenheim | Buy |
| Mar-01-21 | Initiated | Berenberg | Buy |
| Oct-28-20 | Initiated | Northland Capital | Outperform |
| Jul-14-20 | Initiated | Cowen | Outperform |
| Jul-14-20 | Initiated | Goldman | Neutral |
| Jul-14-20 | Initiated | Morgan Stanley | Overweight |
| Jul-14-20 | Initiated | Piper Sandler | Overweight |
View All
Repare Therapeutics Inc Stock (RPTX) Latest News
Smart tools for monitoring Repare Therapeutics Inc.’s price actionTrade Volume Report & Weekly Setup with ROI Potential - newser.com
Candlestick signals on Repare Therapeutics Inc. stock todayNew Guidance & Accurate Buy Signal Notifications - newser.com
Can Repare Therapeutics Inc. stock rebound after recent weaknessPortfolio Gains Summary & Community Consensus Picks - newser.com
Why Repare Therapeutics Inc. stock could rally in 2025Analyst Upgrade & Technical Pattern Based Signals - newser.com
Analyzing Repare Therapeutics Inc. with multi timeframe charts2025 Fundamental Recap & Reliable Price Breakout Alerts - newser.com
Volume spikes in Repare Therapeutics Inc. stock – what they meanAnalyst Downgrade & Low Drawdown Momentum Ideas - newser.com
Risk adjusted return profile for Repare Therapeutics Inc. analyzedDay Trade & Fast Momentum Entry Tips - newser.com
Why Repare Therapeutics Inc. stock remains resilientMarket Risk Analysis & Growth Focused Stock Reports - newser.com
Is Repare Therapeutics Inc. stock attractive for ETFsJuly 2025 Breakouts & Verified Entry Point Signals - newser.com
How Repare Therapeutics Inc. stock compares to industry benchmarks2025 Market Outlook & Risk Managed Investment Strategies - newser.com
Is Repare Therapeutics Inc. stock near bottom after declineJuly 2025 Update & Fast Gain Swing Alerts - newser.com
How to monitor Repare Therapeutics Inc. with trend dashboardsJuly 2025 Setups & Technical Pattern Based Buy Signals - newser.com
Repare Therapeutics Inc. stock volume spike explainedJuly 2025 Closing Moves & Verified Momentum Stock Ideas - newser.com
Published on: 2025-11-01 00:17:06 - newser.com
Repare Therapeutics (RPTX) Projected to Post Earnings on Thursday - MarketBeat
Real time scanner hits for Repare Therapeutics Inc. explained2025 Biggest Moves & Precise Entry and Exit Recommendations - newser.com
How to interpret RSI for Repare Therapeutics Inc. stockJuly 2025 Catalysts & Weekly Momentum Picks - newser.com
Repare Therapeutics Inc. (RPTX) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
HC Wainwright Issues Positive Outlook for RPTX Earnings - MarketBeat
Here's Why Repare Therapeutics (NASDAQ:RPTX) Must Use Its Cash Wisely - Yahoo Finance
Q3 EPS Forecast for Repare Therapeutics Increased by Analyst - Defense World
Repare Therapeutics Inc. (NASDAQ:RPTX) Receives Average Rating of "Hold" from Analysts - MarketBeat
Repare Therapeutics’ Promising Study on Advanced Solid Tumors: A Closer Look - MSN
Q1 Earnings Forecast for RPTX Issued By HC Wainwright - MarketBeat
Can Repare Therapeutics Inc. stock deliver sustainable ROEQuarterly Earnings Report & High Accuracy Buy Signal Tips - Fundação Cultural do Pará
Repare Therapeutics stock price target cut as H.C. Wainwright questions drug candidate - Investing.com Nigeria
Repare Therapeutics Inc Stock (RPTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.64%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):